• Home
  • >
  • Orchid Pharma Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/orchid-pharma-ltd.png Logo

Orchid Pharma Ltd Financial Statement

Orchid Pharma Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Dec 2023Sep 2023Jun 2023
Revenue228.03206.94184.81
Operating Expense184.68175.06160.78
Net Profit30.5520.2410.78
Net Profit Margin13.49.785.83
Earning Per Share6.424.42.64
EBIDTA43.3631.8824.04
Effective Tax RateTBATBATBA

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Orchid Pharma Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual665.9559.56450.06
Operating Expenses Annual582.28506.42400.27
Operating Profit Annual135.48120.6143.72
Interest Annual32.2332.0151.34
Depreciation54.7886.99114.17
Net Profit Annual53.09-60.42-95.25
Tax AnnualTBATBATBA

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Orchid Pharma Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning4.3115.6989.89
Cash Flow from Operations18.3492.4723.59
Cash Flow from Investing-31.21112.9467.21
Cash Flow from Financing31.17-216.8-164.99
Cash Flow at the End22.64.3115.69

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Orchid Pharma Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)15.4611.279.91
PBIT Margin (%)7.23-4.28-14.29
PBT Margin (%)7.01-4.15-14.02
Net PROFIT Margin (%)8.14-0.86-25.99
Return On Networth / Equity (%)0.290.06TBA
Return On Networth /Employed(%)1.47-1.1TBA
Return On Assets (%)5.53-0.47-9.62
Total Debt / Equity(X)0.430.530.69
Asset Turnover Ratio (%)0.680.550.37

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Orchid Pharma Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual573.09583.7670.45
Total Current Assets Annual501.01397.65549.86
Non Current Assets Annual724.2712.91687.4
Total Shareholders Funds Annual688.65647.38652.91
Total Assets Annual1,225.211,110.561,237.25

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Orchid Pharma Ltd Earning Calls
Dec 2023
EPS beaten by 6.55 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Orchid Pharma Ltd has a market capitalization of 1,568.98 Cr. Value Research classifies it as a Small-Cap company.

Yes, Orchid Pharma Ltd is debt-free with a debt-to-equity ratio of 0.48.

In FY 2023, Orchid Pharma Ltd recorded a total revenue of approximately 665.9 Cr marking a significant milestone in the company's financial performance.

Orchid Pharma Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.9% and 0.2% annually, respectively..

Orchid Pharma Ltd's current PE ratio is 33.87.

Orchid Pharma Ltd's ROCE averaged -1.3% from the FY ending March 2021 to 2023, with a median of -2.7%. It peaked at 4.7% in March 2023, reflecting strong capital efficiency over the period..

Orchid Pharma Ltd's latest EBIT is Rs. 80.7 Cr, surpassing the average EBIT of Rs. 16.36 Cr over the 5 years..